Scinai Immunotherapeutics Ltd. (SCNI) — Institutional Holders, Q2 2026
11 institutional investment managers reported a SCNI position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $46.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
SCNI in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
New positions
7
Added to
2
Trimmed
1
Sold out
0
Biggest buyers
- CITADEL ADVISORSNew · +62,257 sh+$15.7K
- ARMISTICE CAPITALNew · +35,942 sh+$9.1K
- Virtu FinancialNew · +19,485 sh+$4.9K
- StoneX GroupNew · +13,092 sh+$3.3K
- CAPTRUST FINANCIAL ADVISORSNew · +12,035 sh+$3.0K
Biggest sellers
- XTX Topco LtdTrimmed · -7,277 sh-$1.8K
SCNI 13F holders ranked 1–11 of 11
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 62,257 sh | 62,257 | $15.7K | 0.00% | New |
| 2 | ARMISTICE CAPITAL#2 · 35,942 sh | 35,942 | $9.1K | <0.01% | New |
| 3 | Virtu Financial#3 · 19,485 sh | 19,485 | $5.0K | <0.01% | New |
| 4 | StoneX Group#4 · 13,092 sh | 13,092 | $4.6K | <0.01% | New |
| 5 | XTX Topco Ltd#5 · 16,764 sh | 16,764 | $4.2K | <0.01% | -30.3% |
| 6 | RHUMBLINE ADVISERS#6 · 13,513 sh | 13,513 | $3.4K | 0.00% | +619.5% |
| 7 | CAPTRUST FINANCIAL ADVISORS#7 · 12,035 sh | 12,035 | $3.0K | 0.00% | New |
| 8 | UBS Group AG#8 · 3,955 sh | 3,955 | $1.0K | 0.00% | +330.4% |
| 9 | MORGAN STANLEY#9 · 58 sh | 58 | $15.00 | 0.00% | 0.0% |
| 10 | HRT FINANCIAL#10 · 12,088 sh | 12,088 | $3.00 | 0.00% | New |
| 11 | ROYAL BANK OF CANADA#11 · 815 sh | 815 | $0.00 | 0.00% | New |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.